M
Exchange
—
Entity type
operating
Fiscal year end
Mar 31
Headquarters
CA
Recent Filings
- SC 13D/A87.9 KBMyovant Sciences Ltd.Mar 6, 8:10 AM ET·0001193125-23-060730
- SC 13G47.8 KBMyovant Sciences Ltd.Feb 17, 4:29 PM ET·0000899140-23-000441
- SC 13G/A10.1 KBMyovant Sciences Ltd.Feb 9, 2:25 PM ET·0001274173-23-000018
- SC 13G8.9 KBMyovant Sciences Ltd.Feb 9, 7:57 AM ET·0000318989-23-000038
- SC 13G/A32.9 KBMyovant Sciences Ltd.Feb 6, 2:36 PM ET·0000846087-23-000026
- 10-Q9.8 MBMyovant Sciences Ltd.Jan 26, 4:13 PM ET·0001679082-23-000025
- 8-K395.9 KBMyovant Sciences Ltd.Jan 26, 4:06 PM ET·0001679082-23-000023
Insiders
9- Arjona Ferreira Juan CamiloChief Medical Officer
- GUINAN MARKDirector
- KARBE FRANKPrincipal Fin'l & Accounting
- Lang MatthewGeneral Counsel & Corp. Secy.
- Marek David CDirector, Principal Executive Officer
- Merendino LaurenChief Commercial Officer
- POTTER MYRTLE SDirector
- Sumitomo Chemical Co., Ltd.10% Owner
- Sumitomo Pharma Co., Ltd.10% Owner
Tickers
No tickers on record
Addresses
business
SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE
LONDON, X0, SW1Y 4LB
mailing
SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE
LONDON, X0, SW1Y 4LB